Lipid Lowering Drugs

Question 1

Lipid lowering drugs name ?

Answer 1

Predominantly cholesterol lowering agents

HMG-CoA Reductase inhibitor (Statin)
AtOR-rosu-lo-flu-sim-pita—-vastatin

Cholesterol absorption inhibitor
eztimibe

Bile acid binding resin
colestipol

niacin-V-B3

Predominately TG lowering agents
Fibrates/Fibric acid derivatives - FenoFibrate

Highly polyunsaturated long chain n=3 fatty acids
Eicosapentanoic acid
Docosahexanoic acid

page-446

Question 2

Mechanism of Atorvastatin

Answer 2

Inhibit HMG-CoA REDUCTASE
=block the rate limiting steps of cholesterol synthesis
=dec cholesterol synthesis
=dec VLDL LDL

Increase LDL receptor
=inc cell surface LDL receptor
=inc binding of LDL WITH ITS RECEPTOR
=inc internationalization
=inc catabolism of LDL
=dec plasma cholesterol

447

Question 3

Indication of atorvastatin ?

Answer 3

1. Hyperlipidemia
2. Dyslipidemia
3. After acute coronary syndrome

447

Question 4

Atorvastatin in Heart disease ?

Answer 4

1. dec LDL
2. inc stability of atherosclerotic lesion
3. after acute coronary syndrome

447

Question 5

A/E of atorvastatin ?

Answer 5

1. Myopathy
2. Myalgia
3. Myositis
4. Rhabdomyolysis
5. Biochemical abnormalities in LFT
6. Inc bleeding tendency

448 page

Question 6

Contraindications of Atorvastatin ?

Answer 6

1. Nursing child
2. Preganancy
3. Children
4. Teenegers

Question 7

Mechanism of Fenofibrate ?

Answer 7

1. Via LPL = inc lipolysis of TG
2. dec VLDL
3. dec TG
4. Stimulate PPAR-Alpha = via LPL = Via LPL = inc lipolysis of TG

LPL= Lipoprotein Lipase
PPAR= Peroxisome Proliferator Activated Recepto

Question 8

Indication of fenofibrate ?

Answer 8

1. HyperTriGlyCeridamias
2. DysBetaLipoProteinema

448

Question 9

Contraindication of fenofibrate ?

Answer 9

1. Preganancy
2. Renal f
3. Hepatic f
4. Lactation

448

Question 10

A/E of fenofibrate ?

Answer 10

1. Myopathy
2. Myalgia
3. Myositis
4. inc risk of bleeding
5. inc risk of gall stone formation
6. GIT abnormalities

448